The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Will the Ubiquitin System Furnish as Many Drug Targets as Protein Kinases?
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., McArthur, G., Judson, I. R., Heinrich, M. C., Morgan, J. A., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69446-4 · Cited by 2,607
The selectivity of protein kinase inhibitors: a further update
Bain, J., Plater, L., Elliott, M., Shpiro, N., Hastie, C. J., Mclauchlan, H., Klevernic, I., Arthur, J. S. C., Alessi, D. R., & Cohen, P. (2007) · Biochemical Journal · doi:10.1042/bj20070797 · Cited by 2,520
Self-citationProtein kinases — the major drug targets of the twenty-first century?
Cohen, P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd773 · Cited by 2,186
Self-citationIdentification of a Primary Target of Thalidomide Teratogenicity
Ito, T., Ando, H., Suzuki, T., Ogura, T., Hotta, K., Imamura, Y., Yamaguchi, Y., & Handa, H. (2010) · Science · doi:10.1126/science.1177319 · Cited by 2,136
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., et al. (2009) · Nature · doi:10.1038/nature07884 · Cited by 1,990
The origins of protein phosphorylation
Cohen, P. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e127 · Cited by 1,139
Self-citationThe tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination
Kovalenko, A., Chable-Bessia, C., Cantarella, G., Israël, A., Wallach, D., & Courtois, G. (2003) · Nature · doi:10.1038/nature01802 · Cited by 1,016
Building ubiquitin chains: E2 enzymes at work
Ye, Y., & Rape, M. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2780 · Cited by 989
CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members
Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., Farmer, H., Ashworth, A., & Mosialos, G. (2003) · Nature · doi:10.1038/nature01803 · Cited by 961
Involvement of linear polyubiquitylation of NEMO in NF-κB activation
Tokunaga, F., Sakata, S.-I., Saeki, Y., Satomi, Y., Kirisako, T., Kamei, K., Nakagawa, T., Kato, M., Murata, S., Yamaoka, S., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1821 · Cited by 942
Orchestration of the DNA-Damage Response by the RNF8 Ubiquitin Ligase
Kolas, N. K., Chapman, J. R., Nakada, S., Ylanko, J., Chahwan, R., Sweeney, F. D., Panier, S., Mendez, M., Wildenhain, J., Thomson, T. M., et al. (2007) · Science · doi:10.1126/science.1150034 · Cited by 894
Enhancement of proteasome activity by a small-molecule inhibitor of USP14
Lee, B.-H., Lee, M. J., Park, S., Oh, D.-C., Elsasser, S., Chen, P.-C., Gartner, C., Dimova, N., Hanna, J., Gygi, S. P., et al. (2010) · Nature · doi:10.1038/nature09299 · Cited by 893
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Tatham, M. H., Geoffroy, M.-C., Shen, L., Plechanovova, A., Hattersley, N., Jaffray, E. G., Palvimo, J. J., & Hay, R. T. (2008) · Nature Cell Biology · doi:10.1038/ncb1716 · Cited by 847
Duda, D. M., Borg, L. A., Scott, D. C., Hunt, H. W., Hammel, M., & Schulman, B. A. (2008) · Cell · doi:10.1016/j.cell.2008.07.022 · Cited by 767 · cited 1×
“bring the E2 active site adjacent to the lysine residue of its protein target substrates (Duda et al., 2008; Saha and Deshaies, 2008).”
Jensen, D. E., Proctor, M., Marquis, S. T., Gardner, H. P., Ha, S. I., Chodosh, L. A., Ishov, A. M., Tommerup, N., Vissing, H., Sekido, Y., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1201861 · Cited by 723
A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes
Ciehanover, A., Hod, Y., & Hershko, A. (1978) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(78)91249-4 · Cited by 648
Ubiquitylation in innate and adaptive immunity
Bhoj, V. G., & Chen, Z. J. (2009) · Nature · doi:10.1038/nature07959 · Cited by 634
Zeng, W., Sun, L., Jiang, X., Chen, X., Hou, F., Adhikari, A., Xu, M., & Chen, Z. J. (2010) · Cell · doi:10.1016/j.cell.2010.03.029 · Cited by 615
Muchamuel, T., Basler, M., Aujay, M. A., Suzuki, E., Kalim, K. W., Lauer, C., Sylvain, C., Ring, E. R., Shields, J., Jiang, J., et al. (2009) · Nature Medicine · doi:10.1038/nm.1978 · Cited by 599
Direct activation of protein kinases by unanchored polyubiquitin chains
Xia, Z.-P., Sun, L., Chen, X., Pineda, G., Jiang, X., Adhikari, A., Zeng, W., & Chen, Z. J. (2009) · Nature · doi:10.1038/nature08247 · Cited by 575
CONVERSION OF PHOSPHORYLASE b TO PHOSPHORYLASE a IN MUSCLE EXTRACTS
Fischer, E. H., & Krebs, E. G. (1955) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52289-x · Cited by 543
Mechanism of Ubiquitin-Chain Formation by the Human Anaphase-Promoting Complex
Jin, L., Williamson, A., Banerjee, S., Philipp, I., & Rape, M. (2008) · Cell · doi:10.1016/j.cell.2008.04.012 · Cited by 534
Musone, S. L., Taylor, K. E., Lu, T. T., Nititham, J., Ferreira, R. C., Ortmann, W., Shifrin, N., Petri, M. A., Ilyas Kamboh, M., Manzi, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.202 · Cited by 470
Kisselev, A. F., Callard, A., & Goldberg, A. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509043200 · Cited by 416
Multimodal Activation of the Ubiquitin Ligase SCF by Nedd8 Conjugation
Saha, A., & Deshaies, R. J. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.08.021 · Cited by 396
Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection
Everly, M. J., Everly, J. J., Susskind, B., Brailey, P., Arend, L. J., Alloway, R. R., Roy-Chaudhury, P., Govil, A., Mogilishetty, G., Rike, A. H., et al. (2008) · Transplantation · doi:10.1097/tp.0b013e318190af83 · Cited by 392
Tseng, P.-H., Matsuzawa, A., Zhang, W., Mino, T., Vignali, D. A. A., & Karin, M. (2010) · Nature Immunology · doi:10.1038/ni.1819 · Cited by 387
Development of the Proteasome Inhibitor PS-341
Adams, J. (2002) · The Oncologist · doi:10.1634/theoncologist.7-1-9 · Cited by 369
Function and regulation of protein neddylation
Rabut, G., & Peter, M. (2008) · EMBO reports · doi:10.1038/embor.2008.183 · Cited by 350
Small-molecule inhibitor of USP7/HAUSP ubiquitin protease stabilizes and activates p53 in cells
Colland, F., Formstecher, E., Jacq, X., Reverdy, C., Planquette, C., Conrath, S., Trouplin, V., Bianchi, J., Aushev, V. N., Camonis, J., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0097 · Cited by 321
'Protein Modifications: Beyond the Usual Suspects' Review Series
Ikeda, F., & Đikić, I. (2008) · Cited by 316
MacKay, C., Déclais, A.-C., Lundin, C., Agostinho, A., Deans, A. J., MacArtney, T. J., Hofmann, K., Gartner, A., West, S. C., Helleday, T., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.021 · Cited by 313
The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2
Stevenson, L. F., Sparks, A., Allende‐Vega, N., Xirodimas, D. P., Lane, D. P., & Saville, M. K. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601567 · Cited by 280
Homeostatic MyD88-dependent signals cause lethal inflamMation in the absence of A20
Turer, E. E., Tavares, R. M., Mortier, E., Hitotsumatsu, O., Advincula, R., Lee, B., Shifrin, N., Malynn, B. A., & Ma, A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071108 · Cited by 271
Bianchi, G., Oliva, L., Cascio, P., Pengo, N., Fontana, F., Cerruti, F., Orsi, A., Pasqualetto, E., Mezghrani, A., Calbi, V., et al. (2009) · Blood · doi:10.1182/blood-2008-08-172734 · Cited by 267
Chen, Q., Xie, W., Kuhn, D. J., Voorhees, P. M., Lopez-Girona, A., Mendy, D., Corral, L. G., Krenitsky, V. P., Xu, W., Moutouh-de Parseval, L., et al. (2008) · Blood · doi:10.1182/blood-2007-09-112904 · Cited by 264
UBE2S elongates ubiquitin chains on APC/C substrates to promote mitotic exit
Garnett, M. J., Mansfeld, J., Godwin, C., Matsusaka, T., Wu, J., Russell, P., Pines, J., & Venkitaraman, A. R. (2009) · Nature Cell Biology · doi:10.1038/ncb1983 · Cited by 248
Control of AMPK-related kinases by USP9X and atypical Lys29/Lys33-linked polyubiquitin chains
Al-Hakim, A. K., Zagorska, A., Chapman, L., Deak, M., Peggie, M., & Alessi, D. R. (2008) · Biochemical Journal · doi:10.1042/bj20080067 · Cited by 226
C-terminal modifications regulate MDM2 dissociation and nuclear export of p53
Carter, S., Bischof, O., Dejean, A., & Vousden, K. H. (2007) · Nature Cell Biology · doi:10.1038/ncb1562 · Cited by 225
Inhibitors selective for mycobacterial versus human proteasomes
Lin, G., Li, D., de Carvalho, L. P. S., Deng, H., Tao, H., Vogt, G., Wu, K., Schneider, J., Chidawanyika, T., Warren, J. D., et al. (2009) · Nature · doi:10.1038/nature08357 · Cited by 208
Regulation of cullin-RING E3 ubiquitin-ligases by neddylation and dimerization
Merlet, J., Burger, J., Gomes, J.-E., & Pintard, L. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-8712-7 · Cited by 197
VHL protein‐interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF‐1α
Li, Z., Wang, D., Messing, E. M., & Wu, G. (2005) · EMBO reports · doi:10.1038/sj.embor.7400377 · Cited by 196
What Determines the Specificity and Outcomes of Ubiquitin Signaling?
Ikeda, F., Crosetto, N., & Dikic, I. (2010) · Cell · doi:10.1016/j.cell.2010.10.026 · Cited by 172
Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin‐3
Todi, S. V., Winborn, B. J., Scaglione, K. M., Blount, J. R., Travis, S. M., & Paulson, H. L. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.289 · Cited by 171
An allosteric inhibitor of substrate recognition by the SCFCdc4 ubiquitin ligase
Orlicky, S., Tang, X., Neduva, V., Elowe, N. H., Brown, E., Sicheri, F., & Tyers, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1646 · Cited by 153
Aghajan, M., Jonai, N., Flick, K. M., Fu, F., Luo, M., Cai, X., Ouni, I., Pierce, N. W., Tang, X., Lomenick, B., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1645 · Cited by 144
Lierman, E., Folens, C., Stover, E. H., Mentens, N., Miegroet, H. V., Scheers, W., Boogaerts, M., Vandenberghe, P., Marynen, P., & Cools, J. (2006) · Blood · doi:10.1182/blood-2006-02-004457 · Cited by 132
Smac Mimetics and TNFα: A Dangerous Liaison?
Wu, H., Tschopp, J., & Lin, S. (2007) · Cell · doi:10.1016/j.cell.2007.10.042 · Cited by 128
DNA damage: ubiquitin marks the spot
Bennett, E. J., & Harper, J. W. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb0108-20 · Cited by 91
A novel small-molecule inhibitor of NF-κB signaling
Nakajima, H., Fujiwara, H., Furuichi, Y., Tanaka, K., & Shimbara, N. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.166 · Cited by 64
MDM2 Regulates Dihydrofolate Reductase Activity through Monoubiquitination
Maguire, M., Nield, P. C., Devling, T., Jenkins, R. E., Park, B. K., Polański, R., Vlatković, N., & Boyd, M. T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5271 · Cited by 60
Wrenches in the works: drug discovery targeting the SCF ubiquitin ligase and APC/C complexes
Cardozo, T., & Pagano, M. (2007) · BMC Biochemistry · doi:10.1186/1471-2091-8-s1-s9 · Cited by 35
Cited by
Systematic and Quantitative Assessment of the Ubiquitin-Modified Proteome
Kim, W., Bennett, E. J., Huttlin, E. L., Guo, A., Li, J., Possemato, A., Sowa, M. E., Rad, R., Rush, J., Comb, M. J., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.025 · Cited by 1,613
NF‐κB and the link between inflammation and cancer
DiDonato, J. A., Mercurio, F., & Karin, M. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01099.x · Cited by 1,482
MDM2, MDMX and p53 in oncogenesis and cancer therapy
Wade, M., Li, Y.-C., & Wahl, G. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3430 · Cited by 1,279
Deubiquitylating enzymes and drug discovery: emerging opportunities
Harrigan, J. A., Jacq, X., Martin, N. M., & Jackson, S. P. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.152 · Cited by 940
Cardiovascular Toxic Effects of Targeted Cancer Therapies
Moslehi, J. J. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1100265 · Cited by 635
Metadata
- Authors
- Cohen, P., & Tcherpakov, M.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2010-11
- Volume
- 143
- Issue
- 5
- Pages
- 686-693
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2014607535
- Cited by
- 271
- References
- 52
- FWCI
- 10.40
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.